Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China
· Delayed Price · Currency is CNY 10.92
-0.08 (-0.73%)
Apr 30, 2026, 2:55 PM CST
SHE:300485 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 5,298 | 5,096 | 3,376 | 5,101 | 5,770 | 6,353 | Upgrade
|
| Market Cap Growth | 45.70% | 50.93% | -33.80% | -11.60% | -9.17% | -10.64% | Upgrade
|
| Enterprise Value | 3,778 | 3,486 | 1,875 | 4,044 | 4,529 | 5,091 | Upgrade
|
| Last Close Price | 11.00 | 10.58 | 7.01 | 10.56 | 11.85 | 12.86 | Upgrade
|
| PE Ratio | 363.62 | 349.74 | - | 49.56 | 28.19 | 15.79 | Upgrade
|
| Forward PE | - | 27.14 | 27.14 | 27.14 | 27.14 | 27.14 | Upgrade
|
| PS Ratio | 13.09 | 12.59 | 8.11 | 10.70 | 7.86 | 6.05 | Upgrade
|
| PB Ratio | 1.56 | 1.50 | 1.00 | 1.47 | 1.69 | 1.94 | Upgrade
|
| P/TBV Ratio | 1.60 | 1.54 | 1.03 | 1.52 | 1.75 | 2.01 | Upgrade
|
| P/FCF Ratio | - | - | 96.89 | - | 85.93 | 46.25 | Upgrade
|
| P/OCF Ratio | 195.66 | 188.19 | 24.83 | 240.48 | 52.25 | 34.66 | Upgrade
|
| EV/Sales Ratio | 9.33 | 8.61 | 4.50 | 8.49 | 6.17 | 4.85 | Upgrade
|
| EV/EBITDA Ratio | 125.89 | 117.54 | 27.03 | 468.15 | 63.22 | 33.70 | Upgrade
|
| EV/EBIT Ratio | - | - | 83.53 | - | 186.82 | 53.36 | Upgrade
|
| EV/FCF Ratio | -51.61 | - | 53.80 | - | 67.45 | 37.06 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | - | - | - | - | Upgrade
|
| Debt / EBITDA Ratio | 0.66 | 0.66 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.45 | -0.45 | -0.46 | -0.34 | -0.33 | -0.39 | Upgrade
|
| Net Debt / EBITDA Ratio | -52.00 | -52.00 | -22.66 | -135.86 | -15.66 | -8.58 | Upgrade
|
| Net Debt / FCF Ratio | 21.07 | 21.07 | -45.10 | 37.02 | -16.70 | -9.43 | Upgrade
|
| Asset Turnover | 0.11 | 0.11 | 0.12 | 0.13 | 0.21 | 0.33 | Upgrade
|
| Inventory Turnover | 1.97 | 1.97 | 1.52 | 1.44 | 1.62 | 1.29 | Upgrade
|
| Quick Ratio | 17.42 | 17.42 | 19.79 | 23.91 | 16.15 | 15.75 | Upgrade
|
| Current Ratio | 18.28 | 18.28 | 20.86 | 26.30 | 17.62 | 17.30 | Upgrade
|
| Return on Equity (ROE) | 0.23% | 0.23% | -2.24% | 2.80% | 6.05% | 12.88% | Upgrade
|
| Return on Assets (ROA) | -0.30% | -0.30% | 0.39% | -0.69% | 0.43% | 1.86% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.60% | -0.59% | 1.09% | -1.37% | 0.90% | 4.70% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.50% | -0.50% | 0.60% | -1.10% | 0.70% | 2.90% | Upgrade
|
| Earnings Yield | 0.28% | 0.29% | -2.04% | 2.02% | 3.55% | 6.33% | Upgrade
|
| FCF Yield | -1.38% | -1.44% | 1.03% | -0.62% | 1.16% | 2.16% | Upgrade
|
| Dividend Yield | 2.62% | 2.84% | - | 0.21% | 0.73% | 1.31% | Upgrade
|
| Payout Ratio | - | 1.72% | - | 40.22% | 39.50% | 7.78% | Upgrade
|
| Buyback Yield / Dilution | 1.24% | 1.24% | -0.35% | -2.93% | 0.58% | 1.07% | Upgrade
|
| Total Shareholder Return | 3.86% | 4.08% | -0.35% | -2.72% | 1.30% | 2.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.